News & Events

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Launched November 2025, the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) program asks drug manufacturers to voluntarily reduce Medicaid’s prices to those paid by a group of seven peer nations including Canada, France, and the United Kingdom — a model known as Most Favored Nation pricing. States would then...

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and The University of Texas at Austin. The authors suggest that recreational cannabis laws do not fully resolve underlying systemic inequities.

The findings,...

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine. The discovery extends the scientific understanding of the immune system, identifies a new strategy for boosting immunity against cancers and potentially offers a new tool for delivering genetic payloads to other cells.

Claire Kenney, an M.D.-Ph.D. student, received the Michael O’Dell Trainee Excellence Award from the New York Celtic Medical Society. The society provides a network for Irish-affiliated physicians in New York City.

Dr. Matthew Robbins, the Louis and Rachel Rudin Foundation Education Scholar and a professor of neurology, received the Residency Program Director Recognition Award from American Academy of Neurology. The award...

Rows of poster boards filled the Griffis Faculty Club at Weill Cornell Medicine, showcasing research ranging from cancer immunology and microbiome science to the emerging field of space biology. Standing beside them, graduate students explained months of work in a matter of minutes, fielding questions from judges, faculty and peers.

The 45th annual Vincent du Vigneaud Memorial Research Symposium held on April 16 had a record number of 153 abstracts submitted this year, including...

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators. The findings help clarify the emerging field of cancer neuroscience and may inform future therapeutic strategies.

In the study, published April 29 in Neuron, the researchers used mouse models of the skin cancer melanoma to examine the...

Even as the national conversation around diversity, equity and inclusion is muted, Weill Cornell Medicine continues its work to make sure everyone has a seat at the table.

That was the message relayed on April 23 by Dr. Linnie Golightly, provost and senior associate dean of academic affairs at CUNY School of Medicine. Dr. Golightly was joined by Dr. Heidi Bender, inaugural associate dean for faculty engagement and inclusion, and Fanesse Acquaye, executive director of the Office of...

Researchers from Weill Cornell Medicine and Boston University School of Public Health have been awarded more than $950,000 from Arnold Ventures to create a “Medicaid Atlas” — a national, data-driven web platform that will illuminate how health care use and spending vary across Medicaid programs, plans and populations. The project will be one of the first major efforts of the...

If it wasn’t for a typo, Dr. William Schpero, a health economist and an assistant professor in population health sciences at Weill Cornell Medicine, may have taken a very different career path.

It was 2010 and he was nearing graduation from Dartmouth College, where he studied biology and government while also writing and editing for the school newspaper. Unsure of whether to pursue a career in medicine or possibly law,...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.” Normally, a B cell matures into a plasma cell that produces antibodies to fight infection, but in this case, the cells are trapped partway through the transition. They switch off key B cell features but never fully mature into functional plasma cells, instead surviving as malignant Hodgkin lymphoma cells, also...

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

The...

Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief and even strengthen the patient-caregiver bond. Weill Cornell Medicine and University of Southern California...

Advancing health equity in medicine requires a clear-eyed understanding of history, a rejection of race-based clinical assumptions and a commitment to transform research into practice, said Dr. Joseph L. Wright, senior vice president and chief health equity officer of the American Academy of Pediatrics (AAP), in his keynote address for Weill Cornell Medicine’s eighth annual Diversity Week.

Dr. Wright delivered the...

A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin caspase-4 (CASP4) does. Instead, the researchers discovered that CASP5 boosts the signal to proliferate in a population of gut cells that maintains a healthy intestinal lining and replaces injured cells with new, healthy ones.

The...

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. The discovery could lead to new therapeutic strategies for blood coagulation disorders, cancers and other conditions in which the protein, called a TMEM16 scramblase, works abnormally.

Scramblases operate within cell membranes, where they alter or “scramble” the normal layered...

To Dr. Laura Riley, Weill Cornell Medicine’s prowess in caring for women from birth to adulthood is the institution’s best kept secret.

“Weill Cornell is uniquely positioned to provide exemplary care to women, helping them live longer and healthier, and creating evidence for treatment and prevention,” said Dr. Riley, chair of the Department of Obstetrics and Gynecology and the Given Foundation Professor in Clinical Obstetrics and...

Temporarily disabling a protein complex that organizes DNA into loops inside the cell’s nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found. However, they also discovered a small group of affected genes that play a critical role in guiding cells to become specific types, for example heart, brain, or liver cells.

The...

A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.

As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children. Weill Cornell Medicine’s Department of Pediatrics, the Cornell Health Policy Center (CHPC) and Ariadne Labs are collaborating to launch the Era of the Child...